Who Owns Alzamend Neuro Stock?
NASDAQ: ALZNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 56.35%
- Held by insiders
- 2.66%
- Institutional holders
- 12
- Institutions 56.4%
- Insiders 2.7%
- Public and other 41.0%
Who owns Alzamend Neuro stock?
Institutional investors own about 56.4% of Alzamend Neuro's shares, spread across 12 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 2.66% of ALZN.
The largest institutional holders are Kmt Wealth Management, LLC (27.54%), Kingsbury Capital Investment Advisors LLC (27.54%) and Geode Capital Management, LLC (0.55%). Together, the top 10 institutions control 56.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their ALZN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALZN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Kmt Wealth Management, LLC | 1.33M | 27.54% | +100.0% |
| Kingsbury Capital Investment Advisors LLC | 1.33M | 27.54% | +134.5% |
| Geode Capital Management, LLC | 26.37K | 0.55% | -42.3% |
| Vanguard Fiduciary Trust Co | 21.02K | 0.44% | 0.0% |
| Vanguard Capital Management LLC | 7.56K | 0.16% | +71.7% |
| Tower Research Capital LLC (TRC) | 3.52K | 0.07% | -43.1% |
| UBS Group AG | 2.35K | 0.05% | -47.8% |
| Blackrock Inc. | 437 | 0.01% | 0.0% |
| SBI Securities Co., Ltd. | 22 | 0.00% | 0.0% |
| IFG Advisory, LLC | 22 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALZN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 19.96K | 0.41% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 7.56K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 4.64K | 0.10% |
Frequently asked questions
Who is the largest shareholder of Alzamend Neuro?
Kmt Wealth Management, LLC is the largest institutional shareholder of ALZN, owning 27.54% of shares outstanding (1.33M shares) as of its latest 13F filing.
What percentage of Alzamend Neuro is owned by institutions?
Institutions own about 56.4% of ALZN shares and 57.9% of the public float.
How much of Alzamend Neuro do insiders own?
Insiders, such as officers and directors, own about 2.66% of ALZN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.